Deka Excilite
Deka
Latest generation Phototherapy with Monochromatic Excimer Light 308nm for effective treatment of psoriasis and vitiligo
- Large treatable surface
- Low operating costs
- No side effects
- No toxic gas bottles
- No medication required
Excilite
;)
Deka Excilite
Legenda
Extremely suitable
Very suitable
Suitable
Indications
- Vitiligo
- Tendon injuries
Product operations
Psoriasis and vitiligo are disorders that are difficult to treat, both for the patient and the practitioner.
Excilite is a new and powerful instrument for the dermatologist, a monochromatic excimer light source (MEL@308nm) for fast treatment of psoriasis and vitiligo. Excilite is designed for the treatment of therapy-resistant lesions on the skin and enables targeted exposure of large areas without irradiating the rest of the body.
Excilite treatments require less time than other UV therapies, including the excimer lasers. Clinical experience shows that only one treatment cycle results in a reduction of the problem in large areas and, as a consequence, an improvement in the patient’s quality of life.
Q&A
What is the difference between excimer lasers and the MEL@308nm?
Both light sources use "excited dimer" or excimer, this is XeCl in the case of 308nm. Both light sources are monochromatic. The laser technology is derived from the ophthalmology sector, while DEKA’s MEL technology originated from industrial applications. The big advantage of MEL technology compared to laser technology is, on the one hand, lower cost price (investment and operating cost), and on the other hand, the larger treatable area.
What is the advantage of MEL@308nm technology compared to classic UVA and UVB technology?
The higher intensities enable treatment of resistant disorders such as palmoplantar psoriasis. Astonishing results were also achieved with vitiligo in various European centres.